Heart rate variability and the metabolic syndrome: A systematic review of the literature

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 8, 2014, Pages 784-793

  Stuckey, Melanie I ^a,b   Tulppo, Mikko P ^c   Kiviniemi, Antti M ^c   Petrella, Robert J ^a,b,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c Verve   (Finland)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

Autonomic nervous system; Cardiovascular risk; Heart rate variability; Metabolic syndrome

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; METABOLIC SYNDROME X; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; FEMALE; HEART RATE; HEART VENTRICLE; HEART VENTRICLE FUNCTION; MALE; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; FEMALE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; METABOLIC SYNDROME X; RISK FACTORS; SEX CHARACTERISTICS; VENTRICULAR DYSFUNCTION;

EID: 84910662918     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2555     Document Type: Article

References (39)

1. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640-1645.
2. Mendis S, Puska P, Norrving B (eds). Global atlas on cardiovascular disease prevention and control. World Health Organization: Geneva, Switzerland, 2011.
3. Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, et al. Cardiometabolic risk in Canada: A detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol 2011; 27(2): e1-e33.
4. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 2010; 141(2): 122-131.
5. Liao D, Cai J, Rosamond WD, et al. Cardiac autonomic function and incident coronary heart disease: A population-based case-cohort study. The ARIC study. Atherosclerosis risk in communities study. Am J Epidemiol 1997; 145(8): 696-706.
6. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: The atherosclerosis risk in communities study, 1987-1998. Circulation 2003; 107(17): 2190-2195.
7. Carnethon MR, Prineas RJ, Temprosa M, et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program. Diabetes Care 2006; 29(4): 914-919.
8. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 1998; 351(9101): 478-484.
9. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59(4): 256-262.
10. Assoumou HGN, Pichot V, Barthelemy JC, et al. Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: The PROOF study. Rejuvenation Res 2010; 13(6): 653-663.
11. Brunner EJ, Hemingway H, Walker BR, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation 2002; 106(21): 2659-2665.
12. Chang C, Yang Y, Lu F, et al. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med 2010; 123(5): 432-438.
13. Chang Y, Lin J, Chen W, et al. Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities. Res Dev Disabil 2012; 33(6): 1701-1707.
14. Gehi AK, Lampert R, Veledar E, et al. A twin study of metabolic syndrome and autonomic tone. J Cardiovasc Electrophysiol 2009; 20(4): 422-428.
15. Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot M. Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation 2005; 111(23): 3071-3077.
16. Jarczok MN, Li J, Mauss D, Fischer JE, Thayer JF. Heart rate variability is associated with glycemic status after controlling for components of the metabolic syndrome. Int J Cardiol 2013; 167(3): 855-861.
17. Koskinen T, Kähönen M, Jula A, et al. Metabolic syndrome and short-term heart rate variability in young adults: The cardiovascular risk in young Finns study. Diabetic Med 2009; 26(4): 354-361.
18. Lee K, Park J, Choi J, Park CG. Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia. J Korean Acad Nurs 2011; 41(6): 788-794.
19. Min JY, Paek D, Cho SI, Min KB. Exposure to environmental carbon monoxide may have a greater negative effect on cardiac autonomic function in people with metabolic syndrome. Sci Total Environ 2009; 407(17): 4807-4811.
20. Min K, Min J, Paek D, Cho S. The impact of the components of metabolic syndrome on heart rate variability: Using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol 2008; 31(5): 584-591.
21. Rasic-Milutinovic ZR, Millicevic DR, Milovanovic BD, Perunicic-Pekovic GB, Pencic BD. Do components of metabolic syndrome contribute to cardiac autonomic neuropathy in non-diabetic patients? Saudi Med J 2010; 31(6): 650-657.
22. Soares-Miranda L, Sandercock G, Vale S, et al. Metabolic syndrome, physical activity and cardiac autonomic function. Diabetes Metab Res 2012; 28(4): 363-369.
23. Stein PK, Barzilay JI, Domitrovich PP, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The cardiovascular health study. Diabetic Med 2007; 24(8): 855-863.
24. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106(25): 3143-3421.
25. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112(17): 2735-2752.
26. Alberti KGMM, Aschne P, Assal JP, et al. Definition, diagnosis and classification of Diabetes Mellitus and its complications: Report of a WHO Consultation. Part 1: Diagnosis and classification of Diabetes Mellitus, Geneva, Switzerland, 1999.
27. The IDF consensus worldwide definition of the metabolic syndrome: International Diabetes Foundation. Available from http://www.idf.org/webdata/docs/MetS_def_update2006.pdf. Accessed 23 November 2007
28. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
29. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Circulation 1996; 93(5): 1043-1065.
30. Laaksonen DE, Laitinen T, Schonberg J, Rissanen A, Niskanen LK. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J Hypertens 2003; 21(2): 371-378.
31. Kishi T, Hirooka Y, Konno S, Sunagawa K. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome. J Hypertens 2012; 30(8): 1646-1655.
32. Kamen PW, Krum H, Tonkin AM. Poincaré plot of heart rate variability allows quantitative display of parasympathetic nervous activity in humans. Clin Sci 1996; 91: 201-208.
33. Goldberger AL, Amaral LA, Hausdorff JM, Ivanov PC, Peng CK, Stanley HE. Fractal dynamics in physiology: Alterations with disease and aging. Proc Natl Acad Sci U S A 2002; 99(Suppl 1): 2466-2472.
34. Tulppo MP, Kiviniemi AM, Hautala AJ, et al. Physiological background of the loss of fractal heart rate dynamics. Circulation 2005; 112(3): 314-319.
35. Tulppo MP, Makikallio TH, Seppanen T, et al. Effects of pharmacological adrenergic and vagal modulation on fractal heart rate dynamics. Clin Physiol 2001; 21(5): 515-523.
36. Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000; 101(1): 47-53.
37. Tentolouris N, Argyrakopoulou G, Katsilambros N. Perturbed autonomic nervous system function in metabolic syndrome. NeuroMol Med 2008; 10(3): 169-178.
38. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham heart study. Circulation 1996; 94(11): 2850-2855.
39. Gallagher EJ, LeRoith D, Karnieli E. nsulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 2010; 77: 511-523.